LP
AZN icon

LMR Partners’s AstraZeneca AZN Stock Holding History

LMR Partners’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.03M Sell
20,425
-688,024
-97% -$133M 0.01% 703
2025
Q4 		$130M Buy
708,449
+40,000
+6% +$7.02M 0.25% 28
2025
Q3 		$103M Buy
668,449
+657,001
+5,739% +$99.4M 0.45% 32
2025
Q2 		$1.6M Buy
11,448
+11,273
+6,442% +$1.58M 0.01% 695
2025
Q1 		$25.7K Sell
175
-70,806
-100% -$10.2M ﹤0.01% 1229
2024
Q4 		$9.3M Buy
70,981
+63,338
+829% +$8.87M 0.08% 261
2024
Q3 		$1.19M Sell
7,643
-5,300
-41% -$856K 0.01% 710
2024
Q2 		$2.02M Sell
12,943
-121,615
-90% -$18.3M 0.02% 543
2024
Q1 		$18.2M Sell
134,558
-4,200
-3% -$556K 0.19% 109
2023
Q4 		$18.7M Sell
138,758
-62,300
-31% -$8.1M 0.21% 114
2023
Q3 		$27.2M Sell
201,058
-287,660
-59% -$39.3M 0.31% 70
2023
Q2 		$70M Buy
488,718
+181,304
+59% +$26.7M 0.78% 21
2023
Q1 		$42.7M Buy
+307,414
New +$41.4M 0.66% 29
2021
Q4 		– Sell
-135,587
Closed -$16.4M – 1154
2021
Q3 		$16.4M Buy
+135,587
New +$15.8M 0.18% 111
2021
Q1 		– Sell
-63,303
Closed -$6.33M – 955
2020
Q4 		$6.33M Sell
63,303
-9,624
-13% -$1.02M 0.1% 92
2020
Q3 		$7.99M Buy
72,927
+52,927
+265% +$5.89M 0.16% 66
2020
Q2 		$2.12M Buy
+20,000
New +$2.07M 0.05% 245

Other funds holding AZN

IA
Investor AB Stockholm, Sweden $15.1B AUM 29.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
VAM
Vanguard Asset Management London, Ec4n 8af $117B AUM

LMR Partners's AZN Position: Q1 2026 in Review

LMR Partners reduced its AstraZeneca (AZN) stake by 97% in Q1 2026, selling an estimated $133M and leaving 20,425 shares worth $4.03M. The position accounts for 0.01% of the portfolio, ranked #703.

LMR Partners first reported a position in AZN in Q2 2020 and has held it in 17 quarters since. The position peaked at $130M in Q4 2025. 1,377 funds tracked by Wall St. Rank hold AZN as of Q1 2026.

  • LMR Partners held 20,425 shares of AstraZeneca worth $4.03M as of Q1 2026.
  • LMR Partners sold 688,024 AstraZeneca shares in Q1 2026, an estimated $133M.
  • AstraZeneca made up 0.01% of LMR Partners's portfolio in Q1 2026, its #703 holding.
  • LMR Partners first reported a position in AstraZeneca in Q2 2020 and has held it in 17 quarters since.
  • LMR Partners's AstraZeneca position peaked at $130M in Q4 2025.
  • 1,377 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2026.

Based on LMR Partners's 13F filing for Q1 2026, filed 15 May 2026.